Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AMGEN INC Director's Dealing 2020

Nov 11, 2020

29819_dirs_2020-11-10_9ed620ab-fbc7-4ec4-9dbc-4f520e65dc04.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2020-11-09

Reporting Person: Williams R Sanders (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-11-09 Common Stock S 250 $242.40 Disposed 4909 Direct

Footnotes

F1: The transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1.